Zoekresultaten - Miguel Ángel Molina‐Vila
- Toon 1 - 20 resultaten van 33
- Ga naar de volgende pagina
-
1
Selective isolation of extracellular vesicles from minimally processed human plasma as a translational strategy for liquid biopsies door Diogo Fortunato, Stavros Giannoukakos, Ana Giménez‐Capitán, Michael Hackenberg, Miguel Ángel Molina‐Vila, Nataša Zarovni
Gepubliceerd in 2022Artigo -
2
Potato Carboxypeptidase Inhibitor, a T-knot Protein, Is an Epidermal Growth Factor Antagonist That Inhibits Tumor Cell Growth door Carmen Blanco‐Aparicio, Miguel Ángel Molina‐Vila, Ester Fernández‐Salas, Marsha L. Frazier, José Manuel Mas, Enrique Querol, Francesc Avilés, Rafael de Llorens
Gepubliceerd in 1998Artigo -
3
Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies door Mariacarmela Santarpía, Andrés Aguilar, Imane Chaib, Andrés F. Cardona, Sara Fancelli, Fernando Laguía, Jillian Wilhelmina Paulina Bracht, Peng Cao, Miguel Ángel Molina‐Vila, Niki Karachaliou, Rafael Rosell
Gepubliceerd in 2020Revisão -
4
KRAS G12C-mutant driven non-small cell lung cancer (NSCLC) door R. Rosell, Jordi Codony‐Servat, Jessica González, Mariacarmela Santarpía, Anisha Jain, Chandan Shivamallu, Yu Wang, Ana Giménez‐Capitán, Miguel Ángel Molina‐Vila, Jonas Nilsson, María González‐Cao
Gepubliceerd in 2023Revisão -
5
Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC) door Carles Codony, Jordi Codony‐Servat, Niki Karachaliou, Miguel Ángel Molina‐Vila, Imane Chaib, José Luis Ramírez, María de los Llanos Gil, Flavio Solca, Trever G. Bivona, Rafael Rosell
Gepubliceerd in 2017Artigo -
6
BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale door Jillian Wilhelmina Paulina Bracht, Niki Karachaliou, Trever G. Bivona, Richard B. Lanman, Iris Faull, Rebecca J. Nagy, Ana Drozdowskyj, Jordi Berenguer, Manuel Fernández-Bruno, Miguel Ángel Molina‐Vila, Rafael Rosell
Gepubliceerd in 2019Artigo -
7
Endobronchial ultrasound-guided transbronchial needle aspiration for identifying EGFR mutations door Ignasi García-Olivé, Eduard Monsó, Felipe Andreo, José Sanz‐Santos, Miguel Tarón, Miguel Ángel Molina‐Vila, María Llatjós, E. Castellà, Teresa Morán, Jordi Bertran-Alamillo, Clara Mayo‐de‐las‐Casas, Cristina Queralt, Rafael Rosell
Gepubliceerd in 2009Artigo -
8
Combinatorial Blood Platelets-Derived circRNA and mRNA Signature for Early-Stage Lung Cancer Detection door Silvia D’Ambrosi, Stavros Giannoukakos, Mafalda Antunes‐Ferreira, Carlos Pedraz‐Valdunciel, Jillian Wilhelmina Paulina Bracht, Nicolas Potie, Ana Giménez‐Capitán, Michael Hackenberg, Alberto Fernández, Miguel Ángel Molina‐Vila, Rafael Rosell, Thomas Würdinger, Danijela Koppers‐Lalic
Gepubliceerd in 2023Artigo -
9
A Sensitive Method for Detecting EGFR Mutations in Non-small Cell Lung Cancer Samples with Few Tumor Cells door Miguel Ángel Molina‐Vila, Jordi Bertran-Alamillo, Noemı́ Reguart, Miquel Tarón, Eva Castellà, Mariona Llatjós, Carlota Costa, Clara Mayo, Anna Pradas, Cristina Queralt, Mónica Botia, M. Perez-Cano, Esther Carrasco, Mireia Tomàs, José Luís Mate, Teresa Morán, Rafael Rosell
Gepubliceerd in 2008Artigo -
10
Nondisruptive p53 Mutations Are Associated with Shorter Survival in Patients with Advanced Non–Small Cell Lung Cancer door Miguel Ángel Molina‐Vila, Jordi Bertran‐Alamillo, Amaya Gascó, Clara Mayo‐de‐las‐Casas, María Sánchez-Ronco, Laia Pujantell-Pastor, Laura Bonanno, Adolfo Favaretto, Andrés F. Cardona, A. Vergnenègre, Margarita Majem, Bartomeu Massutí, Teresa Morán, Enric Carcereny, Santiago Viteri, Rafael Rosell
Gepubliceerd in 2014Artigo -
11
Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non–Small-Cell Lung Cancer Patients door Noemı́ Reguart, Cristina Teixidó, Ana Giménez‐Capitán, Laia Paré, Patricia Galván, Santiago Viteri, Sónia Rodríguez, Vicente Peg, Erika Aldeguer, Núria Viñolas, Jordi Remón, Niki Karachaliou, Esther Conde, Fernando López‐Ríos, Ernest Nadal, Sabine Merkelbach‐Bruse, Reinhard Büttner, Rafael Rosell, Miguel Ángel Molina‐Vila, Aleix Prat
Gepubliceerd in 2017Artigo -
12
AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy door Jordi Bertran‐Alamillo, Valérie Cattan, Marie Schoumacher, Jordi Codony‐Servat, Ana Giménez‐Capitán, F. Cantero, Mike F. Burbridge, Sónia Rodríguez, Cristina Teixidó, Ruth Román, Josep Castellví, Silvia García-Román, Carles Codony, Santiago Viteri, Andrés F. Cardona, Niki Karachaliou, Rafael Rosell, Miguel-Angel Molina-Vila
Gepubliceerd in 2019Artigo -
13
Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer door S. Simonetti, Miguel Ángel Molina‐Vila, Cristina Queralt, Itziar de Aguirre, Clara Mayo, Jordi Bertran-Alamillo, José Javier Sánchez, J.L. González-Larriba, Ulpiano Jiménez, Dolores Isla, Teresa Morán, Santiago Viteri, Carlos Camps, Rosario Garcı́a-Campelo, Bartomeu Massutí, Susana Benlloch, Santiago Ramón y Cajal, Miquel Tarón, Rafael Rosell
Gepubliceerd in 2010Artigo -
14
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer door Kirstine Jacobsen, Jordi Bertran‐Alamillo, Miguel Ángel Molina‐Vila, Cristina Teixidó, Niki Karachaliou, Martin H. Pedersen, Josep Castellví, Mónica Garzón, Carles Codony, Jordi Codony‐Servat, Ana Giménez‐Capitán, Ana Drozdowskyj, Santiago Viteri, Martin R. Larsen, Ulrik Lassen, Enriqueta Felip, Trever G. Bivona, Henrik J. Ditzel, Rafael Rosell
Gepubliceerd in 2017Artigo -
15
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients door Umberto Malapelle, Clara Mayo de-las-Casas, Danilo Rocco, Mónica Garzón, Pasquale Pisapia, Núria Jordana‐Ariza, Maria Russo, Roberta Sgariglia, Caterina De Luca, Francesco Pepe, Alejandro Martínez‐Bueno, Daniela Morales-Espinosa, María González‐Cao, Niki Karachaliou, Santiago Viteri, Claudio Bellevicine, Miguel Ángel Molina‐Vila, Rafael Rosell, Giancarlo Troncone
Gepubliceerd in 2017Artigo -
16
Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients door Niki Karachaliou, María González‐Cao, Guillermo Crespo, Ana Drozdowskyj, Erika Aldeguer, Ana Giménez‐Capitán, Cristina Teixidó, Miguel Ángel Molina‐Vila, Santiago Viteri, María de los Llanos Gil, Salvador Martín‐Algarra, Elisabeth Pérez-Ruíz, Iván Márquez‐Rodas, Delvys Rodríguez‐Abreu, Remedios Blanco, Teresa Puértolas, Maria Angeles Royo, Rafael Rosell
Gepubliceerd in 2018Artigo -
17
HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer door María González‐Cao, Xueting Cai, Jillian Wilhelmina Paulina Bracht, Xuan Han, Yang Yang, Carlos Pedraz‐Valdunciel, Teresa Morán, Javier García-Corbacho, Andrés Aguilar, Reyes Bernabé, Pedro De Marchi, Luciane Sussuchi da Silva, Letícia Ferro Leal, Rui Manuel Reis, Jordi Codony‐Servat, Eloísa Jantus‐Lewintre, Miguel Ángel Molina‐Vila, Peng Cao, Rafael Rosell
Gepubliceerd in 2024Artigo -
18
Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape Project door Stephen P. Finn, Alfredo Addeo, Urania Dafni, Erik Thunnissen, Lukas Bubendorf, Line Bille Madsen, Wojciech Biernat, Eric Verbeken, Javier Hernández‐Losa, Antonio Marchetti, Richard Cheney, Arne Warth, Ernst‐Jan M. Speel, Anne Marie Quinn, Kim Monkhorst, Eloísa Jantus‐Lewintre, Verena Tischler, Nesa Marti, Georgia Dimopoulou, Miguel Ángel Molina‐Vila, Roswitha Kammler, Keith M. Kerr, Solange Peters, Rolf A. Stahel
Gepubliceerd in 2021Artigo -
19
Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions door Sergi Villatoro, Clara Mayo‐de‐las‐Casas, Núria Jordana‐Ariza, Santiago Viteri, Mónica Garzón‐Ibáñez, Irene Moya‐Horno, Beatriz García‐Peláez, María González‐Cao, Umberto Malapelle, Ariadna Balada‐Bel, Alejandro Martínez‐Bueno, Raquel Munhoz da Silveira Campos, Noemı́ Reguart, Margarita Majem, Remei Blanco, Ana Blasco, María José Catalán, Xavier González, Giancarlo Troncone, Niki Karachaliou, Rafael Rosell, Miguel Ángel Molina‐Vila
Gepubliceerd in 2019Artigo -
20
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection door María González‐Cao, Teresa Morán, Judith Dalmau, Javier Garciá Corbacho, Jillian Wilhelmina Paulina Bracht, Reyes Bernabé, Óscar Juan, Javier de Castro, Remei Blanco, Ana Drozdowskyj, Jordi Argilaguet, Andreas Meyerhans, Julià Blanco, Júlia G. Prado, Jorge Carrillo, Bonaventura Clotet, Bartomeu Massutí, Mariano Provencio, Miguel Ángel Molina‐Vila, Clara Mayo de las Casa, Mónica Garzón, Peng Cao, Chung‐Ying Huang, Javier Martínez‐Picado, Rafael Rosell
Gepubliceerd in 2020Artigo
Zoekinstrumenten:
Gerelateerde Onderwerpen
Medicine
Internal medicine
Cancer
Lung cancer
Oncology
Biology
Cancer research
Gene
Pathology
Epidermal growth factor receptor
Biochemistry
Gefitinib
Genetics
Erlotinib
Adenocarcinoma
Chemistry
Colorectal cancer
Concordance
Immunotherapy
KRAS
Mutation
Receptor
Cell biology
Immunohistochemistry
Immunology
Liquid biopsy
T790M
Tyrosine kinase
Bioinformatics
Biopsy